HealthyWomen provides insights on key policy priorities through comment letters and statements written by HealthyWomen experts and partners. We also work with coalitions. Links to some of these letters and statements are below. If there is a particular state or federal issue or proposal that you think HealthyWomen should comment on, please contact us at firstname.lastname@example.org.
April 8, 2019
HealthyWomen joined other consumer and patient focused organizations to support a proposal that would lower prescription drug costs for people with Medicare Part D insurance. The letter outlines various aspects of how the proposal would benefit patients, as well as concerns about uncertainties with how the proposed change would actually work – including the size of potential increases to monthly premiums. Read the letter here.
March 15, 2019
HealthyWomen, with other members of the Coalition for Women's Health Equity, welcomed members of the 116th Congress in a letter outlining the coalition's vision and work to raise awareness about women's health equity. The letter extended the opportunity for engagement and collaboration between the 116th Congress and Coalition groups on the many health equity issues and obstacles now burdening women.
March 6, 2019
HealthyWomen – along with other women's organizations – wrote to all the State Senators in Colorado about safety concerns with a proposal that would enable the importation of prescription drugs. Read the letter here.
February 4, 2019
HealthyWomen opposes proposed changes to Title IX by the Department of Education for handling sexual harassment and assault events involving students. Read our comment letter here.
October 29, 2018
What You Need to Know for Open Enrollment Health Insurance Season, by Beth Battaglino, RN, CEO, HealthyWomen, and Michael Miller, MD, Senior Policy Advisor, HealthyWomen
September 15, 2018
HealthyWomen releases findings from its WomenTalk® survey. More than 1000 women shared their top health care concerns, offering insight into their challenges navigating an increasingly complex health care system.
August 27, 2018
In the Balance: We Need to Ensure Access to Pain Management Options While Confronting the Opioid Crisis, by Phyllis E. Greenberger, MSW, HealthyWomen Senior Vice President for Science and Health Policy
August 21, 2018
August 8, 2018
Congress: Keep the REMS Safety Program Intact, by Phyllis Greenberger, MSW, HealthyWomen Senior Vice President for Policy and Science
July 3, 2018
June 6, 2018
New Poll Shows Women Interested in Medication Quality, Health Care Cost, and Issues in International Trade, by Phyllis Greenberger, MSW, HealthyWomen Senior Vice President for Policy and Science
May 18, 2018
Prevention Is Power for Minority Women's Health, by Phyllis Greenberger, MSW, HealthyWomen Senior Vice President for Policy and Science
April 25, 2018
Nicotine and Women's Health: FDA's Initiative Signals Progress, by Phyllis Greenberger, MSW, HealthyWomen Senior Vice President for Science and Health Policy
April 23, 2018
March 5, 2018
February 8, 2018
February 8, 2018
January 30, 2018
Letter of Concern about Provisions of the "Creating and Restoring Equal Access to Equivalent Samples" (CREATES) Act Leading to Less Rigorous Control of High-Risk Medicines Subject to "Risk Evaluation and Mitigation Strategies (REMS).
December 12, 2017
To Survive the Opioid Addiction Crisis, Women Need More than "Just Say No" Slogans by Phyllis Greenberger, MSW, HealthyWomen Senior Vice President for Science and Health Policy
November 7, 2017
October 6, 2017
Rolling Back Coverage for Birth Control Harms Women and Society by Phyllis Greenberger, MSW, HealthyWomen Senior Vice President for Science and Health Policy
September 8, 2017
July 26, 2017
Keep the Care: HealthyWomen's Call to Action on Capitol Hill, by Phyllis Greenberger, MSW, HealthyWomen Senior Vice President for Policy, Advocacy and Science
July 25, 2017
Statement by HealthyWomen, Allies to Congress: Ensure 55 Million U.S. Women Receive Continued Preventive Care
April 6, 2017
March 9, 2017
Importation is Not the Answer to Drug Prices, by Phyllis Greenberger, MSW, HealthyWomen Senior Vice President for Policy, Advocacy and Science
In the news
Medicare, along with many others who pay for health care, is looking at safety issues in hospitals. Medicare has a specific program that reduces payments to hospitals that have higher rates of infections, other complications, and patient injuries. share